PREMAROBINSONPREMA ROBINSON11944ROBINSON, PREMAAssociate Professorprns:coAuthorOfcoauthor ofprns:endDateend dateFaculty Rankprns:fullNamefull nameprns:grantAwardedBygrant awarded byprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:principalInvestigatorNameprincipal investigator nameprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:startDatestart dateprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAddressvivo:address1address line 1vivo:addressCitycityvivo:addressPostalCodepostal codevivo:addressStatestate or provinceAgreementvivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionGrantvivo:hasResearchArearesearch areasvivo:hasResearcherRoleresearch activitiesvivo:hrJobTitleHR job titleInformation Resourcevivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:personInPositionpositionsPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titleResearcher Rolevivo:researcherRoleOfresearcher role ofRolevivo:roleContributesTocontributes tovivo:sponsorAwardIdsponsor award idrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson25530957Khumbatta M, Firozgary B, Tweardy DJ, Weinstock J, Firozgary G, Bhatena Z, Bulsara T, Siller R, Robinson PBioMed research internationalSomatostatin negatively regulates parasite burden and granulomatous responses in cysticercosis. Biomed Res Int. 2014; 2014:247182.Biomed Res Int2014-07-09T00:00:002014Somatostatin negatively regulates parasite burden and granulomatous responses in cysticercosis.25821814Robinson P, Taffet GE, Engineer N, Khumbatta M, Firozgary B, Reynolds C, Pham T, Bulsara T, Firozgary GBioMed research internationalSubstance P receptor antagonism: a potential novel treatment option for viral-myocarditis. Biomed Res Int. 2015; 2015:645153.Biomed Res Int2015-03-02T00:00:002015Substance P receptor antagonism: a potential novel treatment option for viral-myocarditis.Infectious Diseases, Infection Control, and Employee HealthLeukemiaMD AndersonDIMITRIOS PKONTOYIANNISDIMITRIOS P KONTOYIANNIS8761KONTOYIANNIS, DIMITRIOS PProfessorHAGOP MKANTARJIANHAGOP M KANTARJIAN8501KANTARJIAN, HAGOP MProfessorPABLO COKHUYSENPABLO C OKHUYSEN9655OKHUYSEN, PABLO CProfessor9103671White AC, Robinson P, Kuhn RChemical immunologyTaenia solium cysticercosis: host-parasite interactions and the immune response. Chem Immunol. 1997; 66:209-30.Chem Immunol1997-01-01T00:00:001997Taenia solium cysticercosis: host-parasite interactions and the immune response.9199468Robinson P, Atmar RL, Lewis DE, White ACInfection and immunityGranuloma cytokines in murine cysticercosis. Infect Immun. 1997 Jul; 65(7):2925-31.Infect Immun1997-07-01T00:00:001997Granuloma cytokines in murine cysticercosis.8627504White AC, Baig S, Robinson PThe Journal of parasitologyTaenia saginata oncosphere excretory/secretory peptidases. J Parasitol. 1996 Feb; 82(1):7-10.J Parasitol1996-02-01T00:00:001996Taenia saginata oncosphere excretory/secretory peptidases.26078968Khumbatta M, Firozgary B, Tweardy DJ, Weinstock J, Firozgary G, Bhatena Z, Bulsara T, Siller R, Robinson PBioMed research internationalCorrigendum to "Somatostatin Negatively Regulates Parasite Burden and Granulomatous Responses in Cysticercosis". Biomed Res Int. 2015; 2015:869648.Biomed Res Int2015-05-18T00:00:002015Corrigendum to "Somatostatin Negatively Regulates Parasite Burden and Granulomatous Responses in Cysticercosis".11160015Robinson P, Okhuysen PC, Chappell CL, Lewis DE, Shahab I, Janecki A, White ACInfection and immunityExpression of tumor necrosis factor alpha and interleukin 1 beta in jejuna of volunteers after experimental challenge with Cryptosporidium parvum correlates with exposure but not with symptoms. Infect Immun. 2001 Feb; 69(2):1172-4.Infect Immun2001-02-01T00:00:002001Expression of tumor necrosis factor alpha and interleukin 1 beta in jejuna of volunteers after experimental challenge with Cryptosporidium parvum correlates with exposure but not with symptoms.11509007Robinson P, Okhuysen PC, Chappell CL, Lewis DE, Shahab I, Lahoti S, White ACCytokineExpression of IL-15 and IL-4 in IFN-gamma-independent control of experimental human Cryptosporidium parvum infection. Cytokine. 2001 Jul 07; 15(1):39-46.Cytokine2001-07-07T00:00:002001Expression of IL-15 and IL-4 in IFN-gamma-independent control of experimental human Cryptosporidium parvum infection.14552894Stringer JL, Marks LM, White AC, Robinson PExperimental neurologyEpileptogenic activity of granulomas associated with murine cysticercosis. Exp Neurol. 2003 Oct; 183(2):532-6.Exp Neurol2003-10-01T00:00:002003Epileptogenic activity of granulomas associated with murine cysticercosis.10948171Robinson P, Okhuysen PC, Chappell CL, Lewis DE, Shahab I, Lahoti S, White ACInfection and immunityTransforming growth factor beta1 is expressed in the jejunum after experimental Cryptosporidium parvum infection in humans. Infect Immun. 2000 Sep; 68(9):5405-7.Infect Immun2000-09-01T00:00:002000Transforming growth factor beta1 is expressed in the jejunum after experimental Cryptosporidium parvum infection in humans.12117965Robinson P, White AC, Lewis DE, Thornby J, David E, Weinstock JInfection and immunitySequential expression of the neuropeptides substance P and somatostatin in granulomas associated with murine cysticercosis. Infect Immun. 2002 Aug; 70(8):4534-8.Infect Immun2002-08-01T00:00:002002Sequential expression of the neuropeptides substance P and somatostatin in granulomas associated with murine cysticercosis.74Professor10Assistant Professor54Instructor14Associate Professor6767 Bertner StHouston77030-2603TXDAVIDTWEARDYDAVID TWEARDY11776TWEARDY, DAVIDProfessorUDDALAKBHARADWAJUDDALAK BHARADWAJ11942BHARADWAJ, UDDALAKAssistant Professor2.723430.00276293212research areas4.550180.039245716coauthor of17.51234.1998160similar to1147selected publications12854086Robinson P, Okhuysen PC, Chappell CL, Weinstock JV, Lewis DE, Actor JK, White ACThe Journal of infectious diseasesSubstance P expression correlates with severity of diarrhea in cryptosporidiosis. J Infect Dis. 2003 Jul 15; 188(2):290-6.J Infect Dis2003-07-09T00:00:002003Substance P expression correlates with severity of diarrhea in cryptosporidiosis.26981525Robinson P, Kasembeli M, Bharadwaj U, Engineer N, Eckols KT, Tweardy DJBioMed research internationalSubstance P Receptor Signaling Mediates Doxorubicin-Induced Cardiomyocyte Apoptosis and Triple-Negative Breast Cancer Chemoresistance. Biomed Res Int. 2016; 2016:1959270.Biomed Res Int2016-02-11T00:00:002016Substance P Receptor Signaling Mediates Doxorubicin-Induced Cardiomyocyte Apoptosis and Triple-Negative Breast Cancer Chemoresistance.19436834Robinson P, Garza A, Moore J, Eckols TK, Parti S, Balaji V, Vallejo J, Tweardy DJInternational journal of clinical and experimental medicineSubstance P is required for the pathogenesis of EMCV infection in mice. Int J Clin Exp Med. 2009; 2(1):76-86.Int J Clin Exp Med2009-03-31T00:00:002009Substance P is required for the pathogenesis of EMCV infection in mice.16052094Okhuysen PC, Chappell CL, Lewis DE, Robinson P, White ACAIDS (London, England)Treatment of chronic cryptosporidiosis in AIDS with rIL-12 induces an immune response associated with improvement but severe side-effects. AIDS. 2005 Aug 12; 19(12):1333-4.AIDS2005-08-12T00:00:002005Treatment of chronic cryptosporidiosis in AIDS with rIL-12 induces an immune response associated with improvement but severe side-effects.15466361Kumar A, Murphy R, Robinson P, Wei L, Boriek AMFASEB journal : official publication of the Federation of American Societies for Experimental BiologyCyclic mechanical strain inhibits skeletal myogenesis through activation of focal adhesion kinase, Rac-1 GTPase, and NF-kappaB transcription factor. FASEB J. 2004 Oct; 18(13):1524-35.FASEB J2004-10-01T00:00:002004Cyclic mechanical strain inhibits skeletal myogenesis through activation of focal adhesion kinase, Rac-1 GTPase, and NF-kappaB transcription factor.Authorship 3726725Authorship 37267311Authorship 3726741Authorship 3726751Authorship 3726764Authorship 3726771Authorship 3726784Authorship 3726793Authorship 37268010Authorship 3726816Authorship 3726821Authorship 3726832Authorship 3726842Authorship 3726851Authorship 3727883Authorship 3727891Authorship 3727902Authorship 3727911Authorship 3727922Authorship 3727934Authorship 3728542Authorship 3728555Authorship 3728563Authorship 3728575Authorship 3728581Authorship 3728591Authorship 3728602Authorship 372861116136475Dann SM, Wang HC, Gambarin KJ, Actor JK, Robinson P, Lewis DE, Caillat-Zucman S, White ACThe Journal of infectious diseasesInterleukin-15 activates human natural killer cells to clear the intestinal protozoan cryptosporidium. J Infect Dis. 2005 Oct 01; 192(7):1294-302.J Infect Dis2005-08-23T00:00:002005Interleukin-15 activates human natural killer cells to clear the intestinal protozoan cryptosporidium.23378918Thacker SA, Robinson P, Abel A, Tweardy DJScientific reportsModulation of the unfolded protein response during hepatocyte and cardiomyocyte apoptosis in trauma/hemorrhagic shock. Sci Rep. 2013; 3:1187.Sci Rep2013-02-01T00:00:002013Modulation of the unfolded protein response during hepatocyte and cardiomyocyte apoptosis in trauma/hemorrhagic shock.16995390Patil S, Robinson P, Actor JK, Baig S, White ACThe Journal of parasitologyProinflammatory cytokines in granulomas associated with murine cysticercosis are not the cause of seizures. J Parasitol. 2006 Aug; 92(4):738-41.J Parasitol2006-08-01T00:00:002006Proinflammatory cytokines in granulomas associated with murine cysticercosis are not the cause of seizures.17158891Hernandez J, Lackner A, Aye P, Mukherjee K, Tweardy DJ, Mastrangelo MA, Weinstock J, Griffiths J, D'Souza M, Dixit S, Robinson PInfection and immunitySubstance P is responsible for physiological alterations such as increased chloride ion secretion and glucose malabsorption in cryptosporidiosis. Infect Immun. 2007 Mar; 75(3):1137-43.Infect Immun2006-12-11T00:00:002006Substance P is responsible for physiological alterations such as increased chloride ion secretion and glucose malabsorption in cryptosporidiosis.18163347D'Souza M, Garza MA, Xie M, Weinstock J, Xiang Q, Robinson PThe Journal of parasitologySubstance P is associated with heart enlargement and apoptosis in murine dilated cardiomyopathy induced by Taenia crassiceps infection. J Parasitol. 2007 Oct; 93(5):1121-7.J Parasitol2007-10-01T00:00:002007Substance P is associated with heart enlargement and apoptosis in murine dilated cardiomyopathy induced by Taenia crassiceps infection.17967863Pantenburg B, Dann SM, Wang HC, Robinson P, Castellanos-Gonzalez A, Lewis DE, White ACInfection and immunityIntestinal immune response to human Cryptosporidium sp. infection. Infect Immun. 2008 Jan; 76(1):23-9.Infect Immun2007-10-29T00:00:002007Intestinal immune response to human Cryptosporidium sp. infection.18576802Robinson P, Martin P, Garza A, D'Souza M, Mastrangelo MA, Tweardy DThe Journal of parasitologySubstance P receptor antagonism for treatment of cryptosporidiosis in immunosuppressed mice. J Parasitol. 2008 Oct; 94(5):1150-4.J Parasitol2008-10-01T00:00:002008Substance P receptor antagonism for treatment of cryptosporidiosis in immunosuppressed mice.18576810Garza A, Weinstock J, Robinson PThe Journal of parasitologyAbsence of the SP/SP receptor circuitry in the substance P-precursor knockout mice or SP receptor, neurokinin (NK)1 knockout mice leads to an inhibited cytokine response in granulomas associated with murine Taenia crassiceps infection. J Parasitol. 2008 Dec; 94(6):1253-8.J Parasitol2008-12-01T00:00:002008Absence of the SP/SP receptor circuitry in the substance P-precursor knockout mice or SP receptor, neurokinin (NK)1 knockout mice leads to an inhibited cytokine response in granulomas associated with murine Taenia crassiceps infection.20150970Garza A, Tweardy DJ, Weinstock J, Viswanathan B, Robinson PJournal of biomedicine & biotechnologySubstance P signaling contributes to granuloma formation in Taenia crassiceps infection, a murine model of cysticercosis. J Biomed Biotechnol. 2010; 2010:597086.J Biomed Biotechnol2010-01-28T00:00:002010Substance P signaling contributes to granuloma formation in Taenia crassiceps infection, a murine model of cysticercosis.22346746Robinson P, Garza A, Weinstock J, Serpa JA, Goodman JC, Eckols KT, Firozgary B, Tweardy DJPLoS pathogensSubstance P causes seizures in neurocysticercosis. PLoS Pathog. 2012 Feb; 8(2):e1002489.PLoS Pathog2012-02-09T00:00:002012Substance P causes seizures in neurocysticercosis.Authorship 845366Authorship 846275Authorship 846325Authorship 847491Parasitology ResearchInfection of immunocompetent mice with acid-water-pretreated Cryptosporidium parvum results in weight loss, and intestinal (structural and physiological) alterations (Parasitology Research DOI 10.1007/s00436-007-0785-3). Parasitology Research. 102:567.Infection of immunocompetent mice with acid-water-pretreated Cryptosporidium parvum results in weight loss, and intestinal (structural and physiological) alterations (Parasitology Research DOI 10.1007/s00436-007-0785-3)BioMed Research InternationalErratum. BioMed Research International. 2015.ErratumJournal of Investigative MedicineIntestinal tnfa in cryptosporidiosis. Journal of Investigative Medicine. 44.Intestinal tnfa in cryptosporidiosisBioMed Research InternationalSubstance P Receptor Signaling Mediates Doxorubicin-Induced Cardiomyocyte Apoptosis and Triple-Negative Breast Cancer Chemoresistance. BioMed Research International. 2016.Substance P Receptor Signaling Mediates Doxorubicin-Induced Cardiomyocyte Apoptosis and Triple-Negative Breast Cancer Chemoresistance10669358White AC, Robinson P, Okhuysen PC, Lewis DE, Shahab I, Lahoti S, DuPont HL, Chappell CLThe Journal of infectious diseasesInterferon-gamma expression in jejunal biopsies in experimental human cryptosporidiosis correlates with prior sensitization and control of oocyst excretion. J Infect Dis. 2000 Feb; 181(2):701-9.J Infect Dis2000-02-01T00:00:002000Interferon-gamma expression in jejunal biopsies in experimental human cryptosporidiosis correlates with prior sensitization and control of oocyst excretion.11371698Okhuysen PC, Robinson P, Nguyen MT, Nannini EC, Lewis DE, Janecki A, Chappell CL, White ACAIDS (London, England)Jejunal cytokine response in AIDS patients with chronic cryptosporidiosis and during immune reconstitution. AIDS. 2001 Apr 13; 15(6):802-4.AIDS2001-04-13T00:00:002001Jejunal cytokine response in AIDS patients with chronic cryptosporidiosis and during immune reconstitution.13130414White AC, Robinson P, Okhuysen PCClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaHuman studies provide insight into the pathogenesis, immunology, and treatment of cryptosporidiosis. Clin Infect Dis. 2003 Oct 01; 37(7):989; author reply 989-90.Clin Infect Dis2003-10-01T00:00:002003Human studies provide insight into the pathogenesis, immunology, and treatment of cryptosporidiosis.18040720Garza A, Castellanos-Gonzalez A, Castenallos-Gonzalez A, Griffiths J, Robinson PParasitology researchInfection of immunocompetent mice with acid-water-pretreated Cryptosporidium parvum results in weight loss, and intestinal (structural and physiological) alterations. Parasitol Res. 2008 Feb; 102(3):457-63.Parasitol Res2007-11-28T00:00:002007Infection of immunocompetent mice with acid-water-pretreated Cryptosporidium parvum results in weight loss, and intestinal (structural and physiological) alterations.18547256Garza A, Lackner A, Aye P, D'Souza M, Martin P, Borda J, Tweardy DJ, Weinstock J, Griffiths J, Robinson PJournal of medical primatologySubstance P receptor antagonist reverses intestinal pathophysiological alterations occurring in a novel ex-vivo model of Cryptosporidium parvum infection of intestinal tissues derived from SIV-infected macaques. J Med Primatol. 2008 Jun; 37(3):109-15.J Med Primatol2008-06-01T00:00:002008Substance P receptor antagonist reverses intestinal pathophysiological alterations occurring in a novel ex-vivo model of Cryptosporidium parvum infection of intestinal tissues derived from SIV-infected macaques.EMMARODRIGUEZEMMA RODRIGUEZ13660RODRIGUEZ, EMMAAssistant Professortrue1Assistant ProfessorAssistant ProfessorAuthorship 8871559Authorship 8874121Authorship 8876479D013373Chemicals & Drugs36700.964082Substance PD003457Disorders25860.934684CryptosporidiosisD006099Disorders1131460.876797GranulomaAuthorship 932761330081609Kasembeli MM, Bharadwaj U, Robinson P, Tweardy DJInternational journal of molecular sciencesContribution of STAT3 to Inflammatory and Fibrotic Diseases and Prospects for its Targeting for Treatment. Int J Mol Sci. 2018 Aug 05; 19(8).Int J Mol Sci2018-08-05T00:00:002018Contribution of STAT3 to Inflammatory and Fibrotic Diseases and Prospects for its Targeting for Treatment.D018040Chemicals & Drugs14300.979729Receptors, Neurokinin-12010-05-31NIHROBINSON, PREMA2003-06-01Neuropeptides in the pathogenesis of neurocysticercosisR01NS0426042006-05-31NIHROBINSON, PREMA2003-06-05Substance P in pathogenesis of cryptosporidiosis in AIDSR21AI0542052016-07-31NIHROBINSON, PREMA2013-08-06Role of STAT3 in the pathogenesis of Inflammatory Bowel DiseaseR03AI099405Principal InvestigatorPrincipal InvestigatorPrincipal InvestigatorPharmacological & Pharmaceutical SciencesDepartment of Obstetrics & GynecologyDepartment of Molecular & Human GeneticsMolecular & Human GeneticsObstet & Gyne: Maternal & Fetal MedBaylor College of MedicineUniversity of Houston College of PharmacyGREGCUNYGREG D. CUNY29.72602660000000-95.348164100000004593CUNY, GREGAssociate ProfessorD064729Chemicals & Drugs10170.981663Neurokinin-1 Receptor Antagoniststrue1Associate ProfessorAssociate ProfessorAuthorship 979541332198236Bharadwaj U, Kasembeli MM, Robinson P, Tweardy DJPharmacological reviewsTargeting Janus Kinases and Signal Transducer and Activator of Transcription 3 to Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution. Pharmacol Rev. 2020 04; 72(2):486-526.Pharmacol Rev2020-04-01T00:00:002020Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 to Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution.Authorship 989848232432714Wurster S, Robinson P, Albert ND, Tarrand JJ, Goff M, Swamydas M, Lim JK, Lionakis MS, Kontoyiannis DPThe Journal of infectious diseasesProtective Activity of Programmed Cell Death Protein 1 Blockade and Synergy With Caspofungin in a Murine Invasive Pulmonary Aspergillosis Model. J Infect Dis. 2020 08 17; 222(6):989-994.J Infect Dis2020-08-17T00:00:002020Protective Activity of Programmed Cell Death Protein 1 Blockade and Synergy With Caspofungin in a Murine Invasive Pulmonary Aspergillosis Model.EMILYBLANDEMILY BLAND16042BLAND, EMILYInstructorAuthorship 1017294533917491Legi A, Rodriguez E, Eckols TK, Mistry C, Robinson PCancersSubstance P Antagonism Prevents Chemotherapy-Induced Cardiotoxicity. Cancers (Basel). 2021 Apr 06; 13(7).Cancers (Basel)2021-04-06T00:00:002021Substance P Antagonism Prevents Chemotherapy-Induced Cardiotoxicity.Authorship 1026906534359773Rodriguez E, Pei G, Kim ST, German A, Robinson PCancersSubstance P Antagonism as a Novel Therapeutic Option to Enhance Efficacy of Cisplatin in Triple Negative Breast Cancer and Protect PC12 Cells against Cisplatin-Induced Oxidative Stress and Apoptosis. Cancers (Basel). 2021 Jul 31; 13(15).Cancers (Basel)2021-07-31T00:00:002021Substance P Antagonism as a Novel Therapeutic Option to Enhance Efficacy of Cisplatin in Triple Negative Breast Cancer and Protect PC12 Cells against Cisplatin-Induced Oxidative Stress and Apoptosis.Authorship 1031925634680400Rodriguez E, Pei G, Zhao Z, Kim ST, German A, Robinson PCancersErratum: Rodriguez et al. Substance P Antagonism as a Novel Therapeutic Option to Enhance Efficacy of Cisplatin in Triple Negative Breast Cancer and Protect PC12 Cells against Cisplatin-Induced Oxidative Stress and Apoptosis. Cancers 2021, 13, 3871. Cancers (Basel). 2021 Oct 15; 13(20).Cancers (Basel)2021-10-15T00:00:002021Erratum: Rodriguez et al. Substance P Antagonism as a Novel Therapeutic Option to Enhance Efficacy of Cisplatin in Triple Negative Breast Cancer and Protect PC12 Cells against Cisplatin-Induced Oxidative Stress and Apoptosis. Cancers 2021, 13, 3871.Authorship 1050095135806893Robinson P, Rodriguez E, Mu?oz MJournal of clinical medicineSubstance P-Friend or Foe. J Clin Med. 2022 Jun 22; 11(13).J Clin Med2022-06-22T00:00:002022Substance P-Friend or Foe.true1InstructorInstructorAuthorship 10605241Authorship 1055973335959620Robinson P, Cove?as R, Mu?oz MCurrent medicinal chemistryCombination Therapy of Chemotherapy or Radiotherapy and the Neurokinin-1 Receptor Antagonist Aprepitant: A New Antitumor Strategy? Curr Med Chem. 2023; 30(16):1798-1812.Curr Med Chem2023-01-01T00:00:002023Combination Therapy of Chemotherapy or Radiotherapy and the Neurokinin-1 Receptor Antagonist Aprepitant: A New Antitumor Strategy?36498596Robinson P, Magness E, Montoya K, Engineer N, Eckols TK, Rodriguez E, Tweardy DJJournal of clinical medicineGenetic and Small-Molecule Modulation of Stat3 in a Mouse Model of Crohn's Disease. J Clin Med. 2022 Nov 28; 11(23).J Clin Med2022-11-28T00:00:002022Genetic and Small-Molecule Modulation of Stat3 in a Mouse Model of Crohn's Disease.Authorship 1066925136983138Robinson P, Rosso M, Mu?oz MJournal of clinical medicineNeurokinin-1 Receptor Antagonists as a Potential Novel Therapeutic Option for Osteosarcoma Patients. J Clin Med. 2023 Mar 09; 12(6).J Clin Med2023-03-09T00:00:002023Neurokinin-1 Receptor Antagonists as a Potential Novel Therapeutic Option for Osteosarcoma Patients.Authorship 1074323137296943Robinson P, Montoya K, Magness E, Rodriguez E, Villalobos V, Engineer N, Yang P, Bharadwaj U, Eckols TK, Tweardy DJCancersTherapeutic Potential of a Small-Molecule STAT3 Inhibitor in a Mouse Model of Colitis. Cancers (Basel). 2023 May 30; 15(11).Cancers (Basel)2023-05-30T00:00:002023Therapeutic Potential of a Small-Molecule STAT3 Inhibitor in a Mouse Model of Colitis.Authorship 1084686337958914Cove?as R, Rodr?guez FD, Robinson P, Mu?oz MInternational journal of molecular sciencesThe Repurposing of Non-Peptide Neurokinin-1 Receptor Antagonists as Antitumor Drugs: An Urgent Challenge for Aprepitant. Int J Mol Sci. 2023 Nov 03; 24(21).Int J Mol Sci2023-11-03T00:00:002023The Repurposing of Non-Peptide Neurokinin-1 Receptor Antagonists as Antitumor Drugs: An Urgent Challenge for Aprepitant.2028-09-21NIHDATTA, KIRAN2023-06-01PHASE 1 AND PHASE 2 CLINICAL TRIALS FOR NEXT-GENERATION CORONAVIRUS VACCINES75N91019D00Co-Principal Investigatortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1Assistant ProfessorAssistant Professortrue1Associate ProfessorAssociate Professortrue1ProfessorProfessor